Design, synthesis and biological activity evaluation of novel allosteric inhibitors of the DENV NS2B–NS3 protease

The NS2B–NS3 protease has two inhibitor targets: the catalytic and allosteric sites. Leveraging the unique features of the allosteric site, two series of inhibitors were designed and synthesized based on the binding analysis of lead compounds.